Robert Martell - 13 Feb 2023 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INDP	Stock Option (Right to Buy)	Award	$0	+20,000		$0.000000	20,000	13 Feb 2023	Common Stock	20,000	$1.71	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option vests and becomes exercisable on February 13, 2024.